immunogenclinicaltrials.com | BPDCN Trial

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: /wp-admin/admin-ajax.php Disallow: /wp-admin/ Sitemap: https://immunogenclinicaltrials.com/sitemap.xml Sitemap:

Meta Tags

Title	BPDCN Trial - BPDCN Clinical
Description	What is What is BPDCN? Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare blood cancer. Each year, there are 1000 to 1400 newly diagnosed cases in the United States and Europe combined, and 3 out of 4 diagnosed patients are men.1 BPDCN often
Keywords	N/A

Server Information

WebSite	immunogenclinicaltrials.com
Host IP	141.193.213.10
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

immunogenclinicaltrials.com Valuation

US$384,615

Last updated: 2023-05-19 04:45:24

immunogenclinicaltrials.com has Semrush global rank of 27,519,230. immunogenclinicaltrials.com has an estimated worth of US$ 384,615, based on its estimated Ads revenue. immunogenclinicaltrials.com receives approximately 44,379 unique visitors each day. Its web server is located in United States, with IP address 141.193.213.10. According to SiteAdvisor, immunogenclinicaltrials.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$384,615
Daily Ads Revenue	US$356
Monthly Ads Revenue	US$10,651
Yearly Ads Revenue	US$127,811
Daily Unique Visitors	2,959
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
immunogenclinicaltrials.com. 300 IN	A		IP: 141.193.213.10
immunogenclinicaltrials.com. 300 IN	A		IP: 141.193.213.11
immunogenclinicaltrials.com. 21600 IN	NS		NS Record: ns1-08.azure-dns.com.
immunogenclinicaltrials.com. 21600 IN	NS		NS Record: ns2-08.azure-dns.net.
immunogenclinicaltrials.com. 21600 IN	NS		NS Record: ns3-08.azure-dns.org.
immunogenclinicaltrials.com. 21600 IN	NS		NS Record: ns4-08.azure-dns.info.

HtmlToTextCheckTime:2023-05-19 04:45:24

BPDCN Trial What is BPDCN? Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare blood cancer. Each year, there are 1000 to 1400 newly diagnosed cases in the United States and Europe combined, and 3 out of 4 diagnosed patients are men.1 BPDCN often first appears as an unusual growth or change in appearance on the skin (also called a skin lesion), and may involve lymph nodes, blood, and bone marrow. BPDCN IS AN AGGRESSIVE CANCER. IF YOU OR SOMEONE YOU LOVE HAS BEEN DIAGNOSED, CONSIDER DISCUSSING CLINICAL TRIAL PARTICIPATION WITH YOUR DOCTOR. IF YOU ARE A HEALTHCARE PROFESSIONAL WHO HAS A PATIENT WHO HAS BEEN DIAGNOSED WITH BPDCN, WHETHER OR NOT THEY HAVE RECEIVED PRIOR THERAPY, THEY MAY BE ELIGIBLE TO PARTICPATE IN A CLINICAL TRIAL STUDYING AN EXPERIMENTAL DRUG, IMGN632. Study Locations Why participate in a clinical trial? Clinical trials are research studies. The goal of clinical trials is to find new ways to treat a disease or a condition. Your participation in this trial

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 29 Aug 2022 08:37:16 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 0
Connection: keep-alive
X-Redirect-By: WordPress
Location: https://immunogenclinicaltrials.com/
X-Powered-By: WP Engine
X-Cacheable: non200
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 2
X-Cache-Group: normal
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6zIvciX4ZLiV3%2FdKafik0sXg6hrJwW1s1%2BX0SPJfXOuxFFt1XKdgfTi4NL92i8h06DUrHge8cP3o%2BBH3a%2FOOyEbG8g1QALzmiQe%2BIHnqHHb4pAd%2BCTsMAik9FxMAnOvjRO5xVdKkUVD4Q82NzQ%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 7423f6ba4fa316e3-DME
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 200 
date: Mon, 29 Aug 2022 08:37:17 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
vary: Accept-Encoding,Cookie
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
cache-control: max-age=600, must-revalidate
x-cache: HIT: 5
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=DBxvRHq7prKHe3SzKR2bVAnIDe%2Fz5YWriT1Ms3lWD3cOYkxFdN3xwAu86%2BqjQOZzcIpNodKWJ%2B9OT7e1%2FjYO0L%2BfhIBT2HfUaN1yyHMJaCXN%2Bvr%2Fefzh8X%2FjsxogABXun192qSCX8KGAhWtN0A%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 7423f6bd9de39d70-DME
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

immunogenclinicaltrials.com Whois Information

Domain Name: IMMUNOGENCLINICALTRIALS.COM
Registry Domain ID: 2681597875_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-03-16T21:25:36Z
Creation Date: 2022-03-14T18:15:34Z
Registry Expiry Date: 2027-03-14T18:15:34Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1-08.AZURE-DNS.COM
Name Server: NS2-08.AZURE-DNS.NET
Name Server: NS3-08.AZURE-DNS.ORG
Name Server: NS4-08.AZURE-DNS.INFO
DNSSEC: unsigned
>>> Last update of whois database: 2022-08-29T08:40:44Z <<<

immunogenclinicaltrials.com valuation and analysis